Case number 1:22-cv-00387
Amgen Inc. et al v. USV Private Limited > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 14, 2023 | 18 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (mdb) (Entered: 11/14/2023) (1) |
| Jun 6, 2022 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:21-cv-00662-MN. (dlw) |
| Jun 6, 2022 | 17 | SO ORDERED (7) Docket Text: SO ORDERED re (16 in 1:22-cv-00387-MN, 77 in 1:21-cv-00662-MN) Stipulation and Order for Consolidation. Signed by Judge Maryellen Noreika on 6/6/2022. (dlw) |
| Jun 3, 2022 | 16 | Main Document (3) Docket Text: STIPULATION for Consolidation by Amgen Inc., KAI Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A)(Clark, Cameron) |
| Jun 3, 2022 | 16 | Exhibit A (4) |
| Jun 2, 2022 | 15 | Letter (1) Docket Text: Joint Letter to The Honorable Maryellen Noreika from Karen Jacobs regarding Response to the Court's May 16, 2022 Oral Order - re [13] Oral Order,. (Jacobs, Karen) |
| Jun 1, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [14] STIPULATION TO EXTEND TIME for the parties to file a joint letter advising the Court whether they will seek to have this case consolidated with C.A. No. 21-662 and whether the Scheduling Order in the lead case shall govern this case, pursuant to the C filed by Amgen Inc., KAI Pharmaceuticals, Inc. ORDERED by Judge Maryellen Noreika on 6/1/2022. (mdb) |
| May 31, 2022 | 14 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to file a joint letter advising the Court whether they will seek to have this case consolidated with C.A. No. 21-662 and whether the Scheduling Order in the lead case shall govern this case, pursuant to the Courts May 16, 2022 Oral Order (D.I. 13) to June 2, 2022 - filed by Amgen Inc., KAI Pharmaceuticals, Inc.. (Clark, Cameron) |
| May 16, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER - IT IS HEREBY ORDERED that, on or before 5/31/2022, the parties shall file a joint letter advising as to whether the parties will seek to have this matter consolidated into lead case C.A. No. 21-662 and if the Scheduling Order in the lead case should govern this case. ORDERED by Judge Maryellen Noreika on 5/16/2022. (dlw) |
| May 11, 2022 | 12 | Answer to Counterclaim (12) Docket Text: ANSWER to [10] Answer to Complaint, Counterclaim by Amgen Inc., KAI Pharmaceuticals, Inc. (Clark, Cameron) Modified on 5/16/2022 (dlw). |
| Apr 20, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [9] MOTION for Pro Hac Vice Appearance of Attorney Robert F. Green and Christopher T. Griffith filed by USV Private Limited. ORDERED by Judge Maryellen Noreika on 4/20/2022. (dlw) |
| Apr 20, 2022 | 9 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Robert F. Green and Christopher T. Griffith - filed by USV Private Limited. (Lennon, James) |
| Apr 20, 2022 | 10 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, Additional Defenses, COUNTERCLAIM against Amgen Inc., KAI Pharmaceuticals, Inc. by USV Private Limited.(Lennon, James) Modified on 4/20/2022 (dlw). |
| Apr 20, 2022 | 11 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by USV Private Limited. (Lennon, James) |
| Apr 1, 2022 | 8 | Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Counsel (Michelle Streifthau-Livizos) by Amgen Inc., KAI Pharmaceuticals, Inc. (Streifthau-Livizos, Michelle) |
| Mar 31, 2022 | 7 | Affidavit of Service (10) Docket Text: AFFIDAVIT of Service for Summons, Complaint and Related Papers served on USV Private Limited on March 30, 2022, filed by Amgen Inc., KAI Pharmaceuticals, Inc.. (Streifthau-Livizos, Michelle) |
| Mar 30, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
| Mar 25, 2022 | 1 | Main Document (16) Docket Text: COMPLAINT filed against USV Private Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3834309.) - filed by Amgen Inc., KAI Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A-C, # (2) Civil Cover Sheet)(mpb) |
| Mar 25, 2022 | 1 | Exhibit A-C (93) |
| Mar 25, 2022 | 1 | Civil Cover Sheet (1) |
| Mar 25, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) |
| Mar 25, 2022 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 2/28/2022. Date of Expiration of Patent: 6/27/2034.Thirty Month Stay Deadline: 8/28/2024. (mpb) |
| Mar 25, 2022 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,820,938 B2, 10,344,765 B2, and 11,162,500 B2. (mpb) |
| Mar 25, 2022 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amgen Inc. for KAI Pharmaceuticals, Inc. filed by Amgen Inc., KAI Pharmaceuticals, Inc.. (mpb) |
| Mar 25, 2022 | 6 | Summons Issued (2) Docket Text: Summons Issued as to USV Private Limited on 3/25/2022. (mpb) |
| Mar 25, 2022 | 1 | Complaint* (1) |
